Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05376878
Title An Investigational Scan (64Cu-DOTA-Trastuzumab PET/MRI) in Imaging Patients With HER2+ Breast Cancer With Brain Metastasis
Recruitment Recruiting
Gender both
Phase FDA approved
Variant Requirements No
Sponsors City of Hope Medical Center
Indications

Her2-receptor positive breast cancer

Therapies

Trastuzumab

Trastuzumab deruxtecan

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.